Michael Allen
Concepts (264)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Psychomotor Agitation | 25 | 2017 | 65 | 4.150 |
Why?
| Antipsychotic Agents | 23 | 2017 | 194 | 3.720 |
Why?
| Emergency Services, Psychiatric | 16 | 2019 | 33 | 2.600 |
Why?
| Suicide, Attempted | 22 | 2023 | 352 | 2.420 |
Why?
| Suicidal Ideation | 14 | 2023 | 463 | 2.420 |
Why?
| Bipolar Disorder | 24 | 2012 | 233 | 2.390 |
Why?
| Psychotic Disorders | 11 | 2016 | 153 | 1.530 |
Why?
| Emergency Service, Hospital | 17 | 2021 | 1968 | 1.490 |
Why?
| Schizophrenia | 8 | 2017 | 429 | 1.460 |
Why?
| Mass Screening | 16 | 2023 | 1152 | 1.230 |
Why?
| Suicide | 20 | 2023 | 586 | 1.160 |
Why?
| Benzodiazepines | 9 | 2016 | 129 | 1.100 |
Why?
| Restraint, Physical | 6 | 2016 | 67 | 1.070 |
Why?
| Mental Disorders | 11 | 2017 | 1007 | 0.990 |
Why?
| Aggression | 4 | 2016 | 196 | 0.850 |
Why?
| Haloperidol | 5 | 2016 | 36 | 0.820 |
Why?
| Risk Management | 3 | 2019 | 90 | 0.810 |
Why?
| Antimanic Agents | 5 | 2009 | 18 | 0.800 |
Why?
| Emergency Medical Services | 6 | 2016 | 548 | 0.730 |
Why?
| Psychological Tests | 2 | 2017 | 131 | 0.720 |
Why?
| Promethazine | 3 | 2016 | 4 | 0.710 |
Why?
| Telephone | 2 | 2019 | 168 | 0.640 |
Why?
| Professional-Patient Relations | 1 | 2019 | 142 | 0.600 |
Why?
| Psychiatric Status Rating Scales | 14 | 2016 | 523 | 0.580 |
Why?
| Loxapine | 3 | 2012 | 4 | 0.570 |
Why?
| Lurasidone Hydrochloride | 1 | 2017 | 1 | 0.570 |
Why?
| Medical History Taking | 2 | 2017 | 115 | 0.550 |
Why?
| Program Development | 1 | 2019 | 362 | 0.550 |
Why?
| Risk Assessment | 11 | 2019 | 3256 | 0.520 |
Why?
| Injections, Intramuscular | 7 | 2008 | 117 | 0.510 |
Why?
| Physical Examination | 2 | 2017 | 235 | 0.510 |
Why?
| Emergency Medicine | 2 | 2017 | 227 | 0.500 |
Why?
| Anticonvulsants | 2 | 2009 | 197 | 0.460 |
Why?
| Humans | 83 | 2023 | 128524 | 0.430 |
Why?
| Adult | 43 | 2021 | 35315 | 0.430 |
Why?
| Communication | 1 | 2019 | 838 | 0.430 |
Why?
| Depressive Disorder, Major | 3 | 2008 | 347 | 0.420 |
Why?
| Evidence-Based Medicine | 2 | 2009 | 717 | 0.420 |
Why?
| Lithium Carbonate | 2 | 2009 | 6 | 0.410 |
Why?
| Self-Injurious Behavior | 4 | 2021 | 120 | 0.410 |
Why?
| Dibenzothiazepines | 2 | 2009 | 17 | 0.410 |
Why?
| Depression | 4 | 2023 | 1289 | 0.400 |
Why?
| Substance-Related Disorders | 6 | 2008 | 1011 | 0.380 |
Why?
| Acute Disease | 9 | 2017 | 968 | 0.380 |
Why?
| Valproic Acid | 3 | 2006 | 47 | 0.370 |
Why?
| Middle Aged | 29 | 2021 | 30893 | 0.360 |
Why?
| Observation | 3 | 2009 | 51 | 0.350 |
Why?
| Tranquilizing Agents | 2 | 2008 | 2 | 0.330 |
Why?
| Male | 41 | 2021 | 62883 | 0.320 |
Why?
| Violence | 3 | 2011 | 245 | 0.310 |
Why?
| Nicotine | 1 | 2011 | 303 | 0.300 |
Why?
| Female | 41 | 2021 | 68127 | 0.300 |
Why?
| Smoking | 3 | 2011 | 1463 | 0.290 |
Why?
| Prospective Studies | 13 | 2023 | 7043 | 0.290 |
Why?
| Comorbidity | 8 | 2019 | 1540 | 0.280 |
Why?
| Disease Management | 2 | 2016 | 588 | 0.270 |
Why?
| Double-Blind Method | 6 | 2017 | 1860 | 0.270 |
Why?
| Borderline Personality Disorder | 1 | 2007 | 13 | 0.270 |
Why?
| International Cooperation | 1 | 2007 | 173 | 0.270 |
Why?
| Risk Factors | 13 | 2023 | 9727 | 0.270 |
Why?
| Primary Health Care | 6 | 2023 | 1638 | 0.270 |
Why?
| Informed Consent | 1 | 2008 | 174 | 0.270 |
Why?
| Drug Therapy, Combination | 5 | 2016 | 1009 | 0.260 |
Why?
| Psychometrics | 4 | 2015 | 681 | 0.260 |
Why?
| Academic Medical Centers | 2 | 2011 | 473 | 0.250 |
Why?
| Guidelines as Topic | 1 | 2007 | 260 | 0.250 |
Why?
| Alcoholism | 2 | 2015 | 766 | 0.240 |
Why?
| Advisory Committees | 3 | 2017 | 219 | 0.230 |
Why?
| Midazolam | 3 | 2016 | 48 | 0.230 |
Why?
| Hypnotics and Sedatives | 1 | 2005 | 153 | 0.230 |
Why?
| Piperazines | 4 | 2007 | 334 | 0.220 |
Why?
| Motivation | 2 | 2006 | 537 | 0.220 |
Why?
| United States | 16 | 2021 | 13876 | 0.210 |
Why?
| Quality of Health Care | 1 | 2007 | 607 | 0.200 |
Why?
| Young Adult | 9 | 2021 | 12320 | 0.200 |
Why?
| Adolescent | 15 | 2021 | 20213 | 0.200 |
Why?
| Thiazoles | 3 | 2007 | 115 | 0.190 |
Why?
| Activities of Daily Living | 1 | 2005 | 388 | 0.190 |
Why?
| Cost-Benefit Analysis | 3 | 2022 | 581 | 0.190 |
Why?
| Pilot Projects | 2 | 2019 | 1558 | 0.190 |
Why?
| Patient Satisfaction | 1 | 2005 | 644 | 0.180 |
Why?
| Randomized Controlled Trials as Topic | 4 | 2016 | 1358 | 0.170 |
Why?
| Preventive Psychiatry | 1 | 2019 | 7 | 0.170 |
Why?
| Hospitalization | 5 | 2021 | 2071 | 0.160 |
Why?
| Aged | 11 | 2019 | 21971 | 0.160 |
Why?
| Schizophrenic Psychology | 2 | 2011 | 93 | 0.160 |
Why?
| Quetiapine Fumarate | 2 | 2009 | 22 | 0.160 |
Why?
| Lorazepam | 2 | 2016 | 24 | 0.150 |
Why?
| Cognition Disorders | 1 | 2003 | 496 | 0.150 |
Why?
| Health Services Research | 2 | 2013 | 389 | 0.150 |
Why?
| Neuropsychological Tests | 1 | 2002 | 1003 | 0.150 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 3 | 2008 | 236 | 0.140 |
Why?
| Utilization Review | 2 | 2008 | 37 | 0.140 |
Why?
| Quality of Life | 2 | 2008 | 2680 | 0.140 |
Why?
| Consensus | 2 | 2017 | 633 | 0.140 |
Why?
| Drug Administration Schedule | 2 | 2011 | 757 | 0.140 |
Why?
| Risperidone | 2 | 2007 | 28 | 0.140 |
Why?
| Combined Modality Therapy | 4 | 2017 | 1209 | 0.130 |
Why?
| Severity of Illness Index | 7 | 2008 | 2736 | 0.130 |
Why?
| Treatment Outcome | 8 | 2012 | 10163 | 0.130 |
Why?
| Altitude Sickness | 1 | 2017 | 137 | 0.130 |
Why?
| Antidepressive Agents, Second-Generation | 2 | 2007 | 43 | 0.130 |
Why?
| Surveys and Questionnaires | 6 | 2021 | 5346 | 0.130 |
Why?
| Longitudinal Studies | 6 | 2011 | 2697 | 0.130 |
Why?
| Patient Admission | 2 | 2008 | 184 | 0.130 |
Why?
| Antidepressive Agents | 3 | 2008 | 221 | 0.130 |
Why?
| Referral and Consultation | 2 | 2019 | 727 | 0.120 |
Why?
| Quinolones | 2 | 2007 | 122 | 0.120 |
Why?
| Aftercare | 1 | 2017 | 205 | 0.120 |
Why?
| Administration, Inhalation | 3 | 2012 | 664 | 0.120 |
Why?
| Dose-Response Relationship, Drug | 3 | 2011 | 1943 | 0.120 |
Why?
| Patient Discharge | 1 | 2021 | 849 | 0.120 |
Why?
| Multicenter Studies as Topic | 3 | 2019 | 285 | 0.120 |
Why?
| Cognition | 1 | 2022 | 1107 | 0.110 |
Why?
| Decision Support Techniques | 1 | 2018 | 398 | 0.110 |
Why?
| Reproducibility of Results | 3 | 2015 | 3023 | 0.110 |
Why?
| Aged, 80 and over | 5 | 2017 | 7040 | 0.110 |
Why?
| Drug Administration Routes | 1 | 2013 | 38 | 0.110 |
Why?
| Crisis Intervention | 2 | 2019 | 34 | 0.110 |
Why?
| Altitude | 1 | 2017 | 443 | 0.110 |
Why?
| Age of Onset | 5 | 2008 | 493 | 0.100 |
Why?
| Military Personnel | 1 | 2019 | 517 | 0.100 |
Why?
| Patient Safety | 1 | 2015 | 290 | 0.090 |
Why?
| Hospitals, General | 2 | 2009 | 21 | 0.090 |
Why?
| Safety | 3 | 2009 | 329 | 0.090 |
Why?
| Caregivers | 2 | 2009 | 807 | 0.090 |
Why?
| Psychiatric Department, Hospital | 1 | 2011 | 14 | 0.090 |
Why?
| Genetic Predisposition to Disease | 2 | 2010 | 2266 | 0.090 |
Why?
| Transdermal Patch | 1 | 2011 | 15 | 0.090 |
Why?
| Chronic Disease | 1 | 2017 | 1701 | 0.090 |
Why?
| Administration, Oral | 3 | 2008 | 757 | 0.090 |
Why?
| Aripiprazole | 2 | 2007 | 16 | 0.090 |
Why?
| Time Factors | 5 | 2011 | 6503 | 0.090 |
Why?
| Aerosols | 1 | 2011 | 172 | 0.090 |
Why?
| Emergencies | 2 | 2010 | 162 | 0.090 |
Why?
| Family Health | 2 | 2009 | 194 | 0.080 |
Why?
| National Institutes of Health (U.S.) | 1 | 2010 | 123 | 0.080 |
Why?
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2009 | 2 | 0.080 |
Why?
| Placebos | 2 | 2011 | 201 | 0.080 |
Why?
| Psychiatry | 2 | 2016 | 173 | 0.080 |
Why?
| Chromosomes, Human, Pair 6 | 1 | 2010 | 52 | 0.080 |
Why?
| Affect | 2 | 2009 | 285 | 0.080 |
Why?
| Interview, Psychological | 1 | 2009 | 85 | 0.080 |
Why?
| Colorado | 1 | 2019 | 4392 | 0.080 |
Why?
| Linkage Disequilibrium | 1 | 2010 | 256 | 0.080 |
Why?
| Health Personnel | 2 | 2007 | 646 | 0.080 |
Why?
| Diagnosis, Dual (Psychiatry) | 2 | 2006 | 36 | 0.080 |
Why?
| Mental Health | 2 | 2013 | 684 | 0.080 |
Why?
| Long-Term Care | 1 | 2009 | 89 | 0.080 |
Why?
| Health Status | 2 | 2019 | 751 | 0.080 |
Why?
| Internship and Residency | 2 | 2009 | 1054 | 0.080 |
Why?
| Recreation | 1 | 2008 | 21 | 0.080 |
Why?
| Personality Assessment | 2 | 2006 | 80 | 0.080 |
Why?
| Age Factors | 4 | 2019 | 3117 | 0.070 |
Why?
| Hospitals, Psychiatric | 1 | 2008 | 23 | 0.070 |
Why?
| Demography | 2 | 2006 | 277 | 0.070 |
Why?
| Brazil | 1 | 2008 | 104 | 0.070 |
Why?
| Depressive Disorder | 3 | 2008 | 355 | 0.070 |
Why?
| Prevalence | 2 | 2013 | 2549 | 0.070 |
Why?
| Nervous System Diseases | 1 | 2010 | 251 | 0.070 |
Why?
| Follow-Up Studies | 6 | 2017 | 4898 | 0.070 |
Why?
| Treatment Refusal | 1 | 2008 | 87 | 0.070 |
Why?
| Paroxetine | 1 | 2007 | 10 | 0.070 |
Why?
| Bupropion | 1 | 2007 | 41 | 0.070 |
Why?
| Conscious Sedation | 1 | 2008 | 84 | 0.070 |
Why?
| Quality Assurance, Health Care | 1 | 2009 | 316 | 0.070 |
Why?
| Smoking Cessation | 1 | 2011 | 408 | 0.070 |
Why?
| Switzerland | 1 | 2006 | 35 | 0.070 |
Why?
| Narcotics | 1 | 2007 | 47 | 0.070 |
Why?
| Europe | 1 | 2007 | 362 | 0.070 |
Why?
| Diagnosis, Differential | 2 | 2008 | 1416 | 0.070 |
Why?
| Personal Satisfaction | 1 | 2008 | 199 | 0.070 |
Why?
| Alcohol-Related Disorders | 1 | 2007 | 115 | 0.070 |
Why?
| Fluphenazine | 1 | 2006 | 5 | 0.070 |
Why?
| Health Services Misuse | 1 | 2006 | 36 | 0.070 |
Why?
| Bayes Theorem | 1 | 2008 | 368 | 0.060 |
Why?
| Lithium | 1 | 2005 | 37 | 0.060 |
Why?
| Interrupted Time Series Analysis | 2 | 2015 | 52 | 0.060 |
Why?
| Recurrence | 2 | 2007 | 1001 | 0.060 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2010 | 2065 | 0.060 |
Why?
| Curriculum | 2 | 2012 | 921 | 0.060 |
Why?
| Cocaine-Related Disorders | 1 | 2006 | 108 | 0.060 |
Why?
| Personality Inventory | 1 | 2005 | 136 | 0.060 |
Why?
| Serotonin Plasma Membrane Transport Proteins | 1 | 2005 | 74 | 0.060 |
Why?
| Practice Guidelines as Topic | 2 | 2016 | 1490 | 0.060 |
Why?
| Biomedical Research | 1 | 2010 | 646 | 0.060 |
Why?
| Dangerous Behavior | 1 | 2004 | 19 | 0.060 |
Why?
| Statistics as Topic | 1 | 2005 | 304 | 0.060 |
Why?
| Urban Health Services | 1 | 2004 | 61 | 0.050 |
Why?
| Incidence | 2 | 2011 | 2619 | 0.050 |
Why?
| Linear Models | 1 | 2006 | 816 | 0.050 |
Why?
| Marijuana Abuse | 1 | 2006 | 228 | 0.050 |
Why?
| Analysis of Variance | 1 | 2006 | 1271 | 0.050 |
Why?
| Sex Factors | 3 | 2019 | 1949 | 0.050 |
Why?
| Serotonin | 1 | 2005 | 318 | 0.050 |
Why?
| Cross-Sectional Studies | 3 | 2008 | 5040 | 0.050 |
Why?
| Secondary Prevention | 2 | 2017 | 220 | 0.050 |
Why?
| Kaplan-Meier Estimate | 2 | 2017 | 857 | 0.050 |
Why?
| Anxiety Disorders | 1 | 2005 | 347 | 0.050 |
Why?
| Polymorphism, Genetic | 1 | 2005 | 639 | 0.050 |
Why?
| Geriatric Assessment | 1 | 2003 | 205 | 0.050 |
Why?
| Length of Stay | 1 | 2006 | 1121 | 0.040 |
Why?
| Inservice Training | 1 | 2019 | 111 | 0.040 |
Why?
| Disclosure | 1 | 2019 | 111 | 0.040 |
Why?
| Health Status Indicators | 1 | 2019 | 168 | 0.040 |
Why?
| Sensitivity and Specificity | 1 | 2002 | 1820 | 0.040 |
Why?
| DNA | 1 | 2005 | 1392 | 0.040 |
Why?
| Postcards as Topic | 1 | 2017 | 1 | 0.040 |
Why?
| Rhode Island | 1 | 2017 | 26 | 0.040 |
Why?
| Hotlines | 1 | 2017 | 32 | 0.030 |
Why?
| Case Management | 1 | 2017 | 63 | 0.030 |
Why?
| Substance Abuse Detection | 2 | 2009 | 73 | 0.030 |
Why?
| Algorithms | 2 | 2019 | 1616 | 0.030 |
Why?
| Attitude of Health Personnel | 1 | 2004 | 1090 | 0.030 |
Why?
| Cohort Studies | 4 | 2008 | 5369 | 0.030 |
Why?
| Psychotherapy | 1 | 2017 | 159 | 0.030 |
Why?
| Child | 3 | 2021 | 20721 | 0.030 |
Why?
| Disease Progression | 1 | 2003 | 2603 | 0.030 |
Why?
| Meta-Analysis as Topic | 1 | 2016 | 167 | 0.030 |
Why?
| Socioeconomic Factors | 1 | 2019 | 1197 | 0.030 |
Why?
| Research Design | 2 | 2013 | 1038 | 0.030 |
Why?
| Outpatients | 1 | 2017 | 366 | 0.030 |
Why?
| Logistic Models | 2 | 2012 | 1975 | 0.030 |
Why?
| Models, Statistical | 1 | 2017 | 625 | 0.030 |
Why?
| Educational Status | 1 | 2015 | 470 | 0.030 |
Why?
| Societies | 1 | 2012 | 36 | 0.020 |
Why?
| Feasibility Studies | 1 | 2015 | 860 | 0.020 |
Why?
| Animals | 1 | 2013 | 34501 | 0.020 |
Why?
| Case-Control Studies | 2 | 2010 | 3326 | 0.020 |
Why?
| Professional Competence | 1 | 2012 | 95 | 0.020 |
Why?
| Mental Status Schedule | 1 | 2009 | 33 | 0.020 |
Why?
| Health Care Surveys | 1 | 2011 | 557 | 0.020 |
Why?
| Continuity of Patient Care | 1 | 2011 | 278 | 0.020 |
Why?
| International Classification of Diseases | 1 | 2009 | 124 | 0.020 |
Why?
| Checklist | 1 | 2009 | 96 | 0.020 |
Why?
| Chromosome Mapping | 1 | 2010 | 505 | 0.020 |
Why?
| Cyclothymic Disorder | 1 | 2008 | 4 | 0.020 |
Why?
| Chi-Square Distribution | 1 | 2009 | 512 | 0.020 |
Why?
| Databases, Genetic | 1 | 2009 | 228 | 0.020 |
Why?
| Gene Frequency | 1 | 2009 | 504 | 0.020 |
Why?
| Self Concept | 1 | 2009 | 239 | 0.020 |
Why?
| Drug Delivery Systems | 1 | 2011 | 326 | 0.020 |
Why?
| Reference Values | 1 | 2009 | 780 | 0.020 |
Why?
| Documentation | 1 | 2009 | 182 | 0.020 |
Why?
| Dyskinesia, Drug-Induced | 1 | 2007 | 15 | 0.020 |
Why?
| Triage | 1 | 2009 | 211 | 0.020 |
Why?
| Retrospective Studies | 3 | 2009 | 14460 | 0.020 |
Why?
| Quality Indicators, Health Care | 1 | 2009 | 296 | 0.020 |
Why?
| Cooperative Behavior | 1 | 2009 | 425 | 0.020 |
Why?
| Circadian Rhythm | 1 | 2009 | 405 | 0.020 |
Why?
| Models, Psychological | 1 | 2008 | 306 | 0.020 |
Why?
| Brain Injuries | 1 | 2010 | 468 | 0.020 |
Why?
| Patient Care Planning | 1 | 2005 | 148 | 0.010 |
Why?
| Genotype | 1 | 2009 | 1831 | 0.010 |
Why?
| Predictive Value of Tests | 1 | 2009 | 1936 | 0.010 |
Why?
| Drug Interactions | 1 | 2004 | 360 | 0.010 |
Why?
| Forecasting | 1 | 2004 | 358 | 0.010 |
Why?
| Genome-Wide Association Study | 1 | 2009 | 1337 | 0.010 |
Why?
| Drug Overdose | 1 | 2007 | 330 | 0.010 |
Why?
| Research | 1 | 2004 | 409 | 0.010 |
Why?
| Phenotype | 1 | 2010 | 3050 | 0.010 |
Why?
| Alcohol Drinking | 1 | 2007 | 749 | 0.010 |
Why?
| Critical Care | 1 | 2005 | 544 | 0.010 |
Why?
| Pregnancy | 1 | 2010 | 6297 | 0.010 |
Why?
|
|
Allen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|